ConServe Donates October Proceeds to Crohn's Foundation
The Rochester-based accounts receivable firm directed its ConServe Cares proceeds to the Crohn's & Colitis Foundation alongside its Matching Gift Program.
Updated on Nov. 2, 2026 in Philanthropy
Continental Service Group, LLC, doing business as ConServe, donated its October ConServe Cares proceeds to the Crohn's & Colitis Foundation. The gift was made in conjunction with ConServe's Matching Gift Program.
Why it matters
The donation directs corporate charitable funds toward research on Crohn's disease and ulcerative colitis, two chronic inflammatory bowel diseases. It also reflects ConServe's stated practice of supporting local non-profit agencies in the Rochester area.
The Crohn's & Colitis Foundation, founded in 1967, has invested more than $500 million into finding causes, treatments and cures for Crohn's disease and ulcerative colitis, and funded 238 IBD research projects in 2025. The size of ConServe's gift was not disclosed.
The players
ConServe
ConServe is an accounts receivable management service provider headquartered in Rochester, New York, operating under the legal name Continental Service Group, LLC.
Crohn's & Colitis Foundation
The Crohn's & Colitis Foundation is a nonprofit founded in 1967 that funds research into causes, treatments and cures for Crohn's disease and ulcerative colitis.
The details
ConServe, an accounts receivable management service provider that has worked with clients for more than 40 years, gave its October ConServe Cares proceeds to the Foundation. The gift was made in conjunction with the company's Matching Gift Program.
Timeline
1967: The Crohn's & Colitis Foundation is founded.
October: ConServe donates its ConServe Cares proceeds to the Foundation.
2025: The Foundation funds 238 IBD research projects.
Market Landscape
The gift adds a corporate contribution to the Foundation's long-running research effort, which has invested more than $500 million since 1967. It shows how service firms are using matching-gift programs to direct employee and company giving toward specific disease research.
For Rochester-area residents, the donation is a local corporate contribution to a national IBD research effort rather than a change to any service or price. Readers affected by Crohn's disease or ulcerative colitis may find the Foundation's research funding relevant to future treatment options.
The takeaway
Corporate matching programs can multiply the reach of employee and company giving toward specific medical research. Readers interested in IBD research can follow the Crohn's & Colitis Foundation's published funding reports to track where donations go.
Further reading
For more on local giving, browse Philanthropy coverage across the region.
Source note: This article includes information reported by InsideARM.
